PHI with Irritable stomach
How does this condition affect your private health insurance?
Reizmagen, or functional dyspepsia, is a chronic digestive disorder characterized by recurrent upper abdominal symptoms like pain, bloating, early satiety, or a burning sensation. Importantly, no identifiable structural or biochemical abnormalities are found after thorough medical investigations. Its complex etiology involves visceral hypersensitivity, gastric motility disturbances, and psychosocial factors. Stress and certain dietary triggers frequently exacerbate symptoms. While not life-threatening, Reizmagen significantly impairs quality of life. Management focuses on symptom control through dietary adjustments, stress reduction techniques, and medications such as acid suppressants, prokinetics, or neuromodulators, aiming to improve comfort and overall well-being.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 20%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several days to weeks per episode.
Duration of Illness (Lifetime)
Chronic with waxing and waning symptoms; often lifelong.
Cost of Treatment (Initial)
Moderate (e.g., 500-2000 USD for initial diagnosis including endoscopy and medication).
Cost of Treatment (Lifetime)
Significant (e.g., 5,000-20,000 USD or more, due to chronic management, repeat consultations, and ongoing medication).
Mortality Rate
Negligible (the condition itself is not fatal).
Risk of Secondary Damages
Moderate (e.g., reduced quality of life, anxiety, depression, sleep disturbances, potential for nutritional imbalances if severe food avoidance occurs).
Probability of Full Recovery
Moderate (symptom-free periods are common, and some achieve long-term remission, but recurrence is possible).
Underlying Disease Risk
Low for organic causes; moderate for co-occurring functional gastrointestinal disorders (like IBS) or psychological conditions (e.g., anxiety, depression).